Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio

Detalhes bibliográficos
Autor(a) principal: Fernandes, Rósley Weber Alvarenga [UNIFESP]
Data de Publicação: 2012
Outros Autores: Dantas, João Miguel [UNIFESP], Oliveira, Dinaldo Cavalcanti [UNIFESP], Bezerra, Hiram Grando [UNIFESP], Brito Jr., Fabio Sandoli [UNIFESP], Lima, Valter C. [UNIFESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S0066-782X2012005000022
http://repositorio.unifesp.br/handle/11600/7047
Resumo: BACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS). OBJECTIVE: This study aims to assess the impact of BMS and the effect of oral sirolimus on endothelial function. METHODS: Forty-five patients were randomized into three groups: BMS + high-dose oral sirolimus (initial dose of 15 mg, followed by 6 mg/day for four weeks); BMS + low-dose sirolimus (6 mg followed by 2 mg daily for four weeks); and BMS without sirolimus. Changes in vasoconstriction or vasodilation in a 15 mm segment starting at the distal stent end in response to acetylcholine and nitroglycerin were assessed by quantitative angiography. RESULTS: The groups had similar angiographic characteristics. The percent variation in diameter in response to acetylcholine was similar in all groups at the two time points (p = 0.469). Four hours after stenting, the target segment presented an endothelial dysfunction that was maintained after eight months in all groups. In all groups, endothelium-independent vasomotion in response to nitroglycerin was similar at four hours and eight months, with increased target segment diameter after nitroglycerin infusion (p = 0.001). CONCLUSION: The endothelial dysfunction was similarly present at the 15 mm segment distal to the treated segment, at 4 hours and 8 months after stenting. Sirolimus administered orally during 4 weeks to prevent restenosis did not affect the status of endothelium-dependent and independent vasomotion.
id UFSP_df640eac7906d849c2f5f25a92b2c040
oai_identifier_str oai:repositorio.unifesp.br/:11600/7047
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelioImpact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotionStentscoronary vesselsendotheliumsirolimusStentsvasos coronarianosendotéliosirolimusBACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS). OBJECTIVE: This study aims to assess the impact of BMS and the effect of oral sirolimus on endothelial function. METHODS: Forty-five patients were randomized into three groups: BMS + high-dose oral sirolimus (initial dose of 15 mg, followed by 6 mg/day for four weeks); BMS + low-dose sirolimus (6 mg followed by 2 mg daily for four weeks); and BMS without sirolimus. Changes in vasoconstriction or vasodilation in a 15 mm segment starting at the distal stent end in response to acetylcholine and nitroglycerin were assessed by quantitative angiography. RESULTS: The groups had similar angiographic characteristics. The percent variation in diameter in response to acetylcholine was similar in all groups at the two time points (p = 0.469). Four hours after stenting, the target segment presented an endothelial dysfunction that was maintained after eight months in all groups. In all groups, endothelium-independent vasomotion in response to nitroglycerin was similar at four hours and eight months, with increased target segment diameter after nitroglycerin infusion (p = 0.001). CONCLUSION: The endothelial dysfunction was similarly present at the 15 mm segment distal to the treated segment, at 4 hours and 8 months after stenting. Sirolimus administered orally during 4 weeks to prevent restenosis did not affect the status of endothelium-dependent and independent vasomotion.FUNDAMENTO: Não há consenso sobre o impacto do implante de stent sobre a função endotelial no longo prazo. Há relatos de disfunção endotelial aumentada com stent com sirolimus quando comparado com o stent metálico convencional (BMS). OBJETIVO: Este estudo visa a avaliar o impacto do BMS e o efeito do sirolimus por via oral sobre a função endotelial. MÉTODOS: Quarenta e cinco pacientes foram randomizados em três grupos: BMS + altas doses de sirolimus oral (dose inicial de 15 mg, seguida de 6 mg/dia durante quatro semanas); BMS + baixa dose de sirolimus (6 mg, seguida de 2 mg por dia durante quatro semanas) e BMS sem sirolimus. Mudanças na vasoconstrição ou vasodilatação, em um segmento de 15 milímetros começando pelo extremo distal do stent em resposta a acetilcolina e nitroglicerina, foram avaliadas por angiografia quantitativa. RESULTADOS: Os grupos apresentaram características angiográficas semelhantes. A variação percentual de diâmetro em resposta a acetilcolina foi semelhante em todos os grupos, nos dois momentos (p = 0,469). Quatro horas após o implante de stent, o segmento alvo apresentou uma disfunção endotelial que se manteve após oito meses em todos os grupos. Em todos os grupos, a vasomotricidade independente de endotélio em resposta a nitroglicerina foi semelhante, às quatro horas e aos oito meses, com diâmetro do segmento alvo aumentado após a infusão de nitroglicerina (p = 0,001). CONCLUSÃO: A disfunção endotelial esteve igualmente presente no segmento distal de 15 milímetros do segmento tratado, às 4 horas e aos 8 meses após implante do stent. O sirolimus administrado por via oral durante quatro semanas para evitar a reestenose não afetou o estado de vasomotricidade endotélio dependente e independente.Universidade Federal de São Paulo (UNIFESP) Hospital do Rim e HipertensãoUNIFESP, Hospital do Rim e HipertensãoSciELOSociedade Brasileira de Cardiologia - SBCUniversidade Federal de São Paulo (UNIFESP)Fernandes, Rósley Weber Alvarenga [UNIFESP]Dantas, João Miguel [UNIFESP]Oliveira, Dinaldo Cavalcanti [UNIFESP]Bezerra, Hiram Grando [UNIFESP]Brito Jr., Fabio Sandoli [UNIFESP]Lima, Valter C. [UNIFESP]2015-06-14T13:43:41Z2015-06-14T13:43:41Z2012-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion290-299application/pdfapplication/pdfhttp://dx.doi.org/10.1590/S0066-782X2012005000022Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 98, n. 4, p. 290-299, 2012.10.1590/S0066-782X2012005000022S0066-782X2012000400002-en.pdfS0066-782X2012000400002-es.pdfS0066-782X2012000400002-pt.pdf0066-782XS0066-782X2012000400002http://repositorio.unifesp.br/handle/11600/7047WOS:000305765200006porArquivos Brasileiros de Cardiologiainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-05T04:47:38Zoai:repositorio.unifesp.br/:11600/7047Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-05T04:47:38Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion
title Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
spellingShingle Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
Fernandes, Rósley Weber Alvarenga [UNIFESP]
Stents
coronary vessels
endothelium
sirolimus
Stents
vasos coronarianos
endotélio
sirolimus
title_short Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
title_full Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
title_fullStr Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
title_full_unstemmed Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
title_sort Impacto dos stents e do sirolimus por via oral na vasomotilidade coronariana dependente e independente do endotelio
author Fernandes, Rósley Weber Alvarenga [UNIFESP]
author_facet Fernandes, Rósley Weber Alvarenga [UNIFESP]
Dantas, João Miguel [UNIFESP]
Oliveira, Dinaldo Cavalcanti [UNIFESP]
Bezerra, Hiram Grando [UNIFESP]
Brito Jr., Fabio Sandoli [UNIFESP]
Lima, Valter C. [UNIFESP]
author_role author
author2 Dantas, João Miguel [UNIFESP]
Oliveira, Dinaldo Cavalcanti [UNIFESP]
Bezerra, Hiram Grando [UNIFESP]
Brito Jr., Fabio Sandoli [UNIFESP]
Lima, Valter C. [UNIFESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Fernandes, Rósley Weber Alvarenga [UNIFESP]
Dantas, João Miguel [UNIFESP]
Oliveira, Dinaldo Cavalcanti [UNIFESP]
Bezerra, Hiram Grando [UNIFESP]
Brito Jr., Fabio Sandoli [UNIFESP]
Lima, Valter C. [UNIFESP]
dc.subject.por.fl_str_mv Stents
coronary vessels
endothelium
sirolimus
Stents
vasos coronarianos
endotélio
sirolimus
topic Stents
coronary vessels
endothelium
sirolimus
Stents
vasos coronarianos
endotélio
sirolimus
description BACKGROUND: There is no consensus regarding the impact of stenting on long-term endothelial function. There have been reports of increased endothelial dysfunction with sirolimus-eluting stents as compared to bare metal stenting (BMS). OBJECTIVE: This study aims to assess the impact of BMS and the effect of oral sirolimus on endothelial function. METHODS: Forty-five patients were randomized into three groups: BMS + high-dose oral sirolimus (initial dose of 15 mg, followed by 6 mg/day for four weeks); BMS + low-dose sirolimus (6 mg followed by 2 mg daily for four weeks); and BMS without sirolimus. Changes in vasoconstriction or vasodilation in a 15 mm segment starting at the distal stent end in response to acetylcholine and nitroglycerin were assessed by quantitative angiography. RESULTS: The groups had similar angiographic characteristics. The percent variation in diameter in response to acetylcholine was similar in all groups at the two time points (p = 0.469). Four hours after stenting, the target segment presented an endothelial dysfunction that was maintained after eight months in all groups. In all groups, endothelium-independent vasomotion in response to nitroglycerin was similar at four hours and eight months, with increased target segment diameter after nitroglycerin infusion (p = 0.001). CONCLUSION: The endothelial dysfunction was similarly present at the 15 mm segment distal to the treated segment, at 4 hours and 8 months after stenting. Sirolimus administered orally during 4 weeks to prevent restenosis did not affect the status of endothelium-dependent and independent vasomotion.
publishDate 2012
dc.date.none.fl_str_mv 2012-04-01
2015-06-14T13:43:41Z
2015-06-14T13:43:41Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0066-782X2012005000022
Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 98, n. 4, p. 290-299, 2012.
10.1590/S0066-782X2012005000022
S0066-782X2012000400002-en.pdf
S0066-782X2012000400002-es.pdf
S0066-782X2012000400002-pt.pdf
0066-782X
S0066-782X2012000400002
http://repositorio.unifesp.br/handle/11600/7047
WOS:000305765200006
url http://dx.doi.org/10.1590/S0066-782X2012005000022
http://repositorio.unifesp.br/handle/11600/7047
identifier_str_mv Arquivos Brasileiros de Cardiologia. Sociedade Brasileira de Cardiologia - SBC, v. 98, n. 4, p. 290-299, 2012.
10.1590/S0066-782X2012005000022
S0066-782X2012000400002-en.pdf
S0066-782X2012000400002-es.pdf
S0066-782X2012000400002-pt.pdf
0066-782X
S0066-782X2012000400002
WOS:000305765200006
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Arquivos Brasileiros de Cardiologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 290-299
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cardiologia - SBC
publisher.none.fl_str_mv Sociedade Brasileira de Cardiologia - SBC
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268302078246912